ATE347375T1 - Rekombinante hunde-herpesviren - Google Patents
Rekombinante hunde-herpesvirenInfo
- Publication number
- ATE347375T1 ATE347375T1 AT97915994T AT97915994T ATE347375T1 AT E347375 T1 ATE347375 T1 AT E347375T1 AT 97915994 T AT97915994 T AT 97915994T AT 97915994 T AT97915994 T AT 97915994T AT E347375 T1 ATE347375 T1 AT E347375T1
- Authority
- AT
- Austria
- Prior art keywords
- chv
- nucleic acid
- acid molecules
- recombinant
- genomes
- Prior art date
Links
- 241000282465 Canis Species 0.000 title 1
- 241000680578 Canid alphaherpesvirus 1 Species 0.000 abstract 13
- 102000039446 nucleic acids Human genes 0.000 abstract 6
- 108020004707 nucleic acids Proteins 0.000 abstract 6
- 150000007523 nucleic acids Chemical class 0.000 abstract 6
- 102000004169 proteins and genes Human genes 0.000 abstract 3
- 108090000623 proteins and genes Proteins 0.000 abstract 3
- 241001465754 Metazoa Species 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000001225 therapeutic effect Effects 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 241000700605 Viruses Species 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C12N9/1211—Thymidine kinase (2.7.1.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16721—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
- C12N2710/16741—Use of virus, viral particle or viral elements as a vector
- C12N2710/16743—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Virology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/602,010 US5753235A (en) | 1996-02-15 | 1996-02-15 | Recombinant canine herpesviruses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE347375T1 true ATE347375T1 (de) | 2006-12-15 |
Family
ID=24409615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97915994T ATE347375T1 (de) | 1996-02-15 | 1997-02-14 | Rekombinante hunde-herpesviren |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US5753235A (https=) |
| EP (1) | EP0910406B1 (https=) |
| JP (1) | JP2000505297A (https=) |
| AT (1) | ATE347375T1 (https=) |
| AU (1) | AU728676B2 (https=) |
| CA (1) | CA2243662A1 (https=) |
| DE (1) | DE69737058T2 (https=) |
| DK (1) | DK0910406T3 (https=) |
| ES (1) | ES2281098T3 (https=) |
| NZ (1) | NZ331079A (https=) |
| PT (1) | PT910406E (https=) |
| WO (1) | WO1997029772A1 (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
| FR2750865B1 (fr) * | 1996-06-27 | 1998-12-04 | Rhone Merieux | Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2 |
| CN1138533C (zh) * | 1996-09-13 | 2004-02-18 | 利普森有限公司 | 脂质体 |
| CA2245408A1 (en) * | 1997-08-21 | 1999-02-21 | York University | High-throughput screens for enzyme inhibitors |
| CA2671261A1 (en) | 1997-11-06 | 1999-05-20 | Novartis Vaccines And Diagnostics S.R.L. | Neisserial antigens |
| EP1047784B2 (en) | 1998-01-14 | 2015-03-18 | Novartis Vaccines and Diagnostics S.r.l. | Neissera meningitidis antigens |
| EP2261338A3 (en) | 1998-05-01 | 2012-01-04 | Novartis Vaccines and Diagnostics, Inc. | Neisseria meningitidis antigens and compositions |
| WO2000066741A2 (en) | 1999-04-30 | 2000-11-09 | Chiron S.P.A. | Conserved neisserial antigens |
| PT2289545T (pt) | 2000-01-17 | 2016-09-06 | Glaxosmithkline Biologicals Sa | Vacina de omv suplementada contra meningococos |
| FR2804026B1 (fr) * | 2000-01-21 | 2004-06-11 | Merial Sas | Vaccination contre l'herpesvirose canine et vaccins |
| US6551598B2 (en) * | 2000-01-21 | 2003-04-22 | Merial | Vaccination against canine herpesvirosis and vaccines therefor |
| CA2881568C (en) | 2000-10-27 | 2019-09-24 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from streptococcus groups a & b |
| US20030129680A1 (en) * | 2001-10-31 | 2003-07-10 | O'connor Thomas Patrick | Multi-analyte assay device |
| JP2005518182A (ja) * | 2001-03-02 | 2005-06-23 | フロリジーン リミティド | 細胞の視覚的特徴を修飾する配列 |
| GB0107658D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Streptococcus pneumoniae |
| GB0107661D0 (en) | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| JP2004535794A (ja) | 2001-05-03 | 2004-12-02 | チルドレンズ・メディカル・センター・コーポレイション | 精子特異的カチオンチャネルおよびその使用 |
| US8729248B2 (en) | 2001-10-22 | 2014-05-20 | Children's Medical Center Corporation | Sperm-specific cation channel, CATSPER2, and uses therefor |
| RU2331435C2 (ru) | 2001-12-12 | 2008-08-20 | Чирон Срл. | Иммунизация против chlamydia trachomatis |
| WO2004015067A2 (en) * | 2002-08-07 | 2004-02-19 | Children's Medical Center Corporation | Sperm-specific cation channel, catsper-3, and uses therefor |
| WO2004015066A2 (en) * | 2002-08-07 | 2004-02-19 | Children's Medical Center Corporation | Sperm-specific cation channel, catsper-4, and uses therefor |
| EP1562982B1 (en) | 2002-11-15 | 2010-05-05 | Novartis Vaccines and Diagnostics S.r.l. | Unexpected surface proteins in neisseria meningitidis |
| SE0300795D0 (sv) | 2003-03-24 | 2003-03-24 | Isconova Ab | Composition comprising iscom particles and live micro-organisms |
| GB0308198D0 (en) | 2003-04-09 | 2003-05-14 | Chiron Srl | ADP-ribosylating bacterial toxin |
| GB0315323D0 (en) * | 2003-07-01 | 2003-08-06 | Royal Veterinary College | Vaccine composition |
| US9023366B2 (en) | 2003-07-01 | 2015-05-05 | The Royal Veterinary College | Vaccine composition for vaccinating dogs against canine infectious respiratory disease (CIRD) |
| US8007806B2 (en) * | 2005-01-20 | 2011-08-30 | Isconova Ab | Vaccine composition comprising a fibronectin binding protein or a fibronectin binding peptide |
| EP2333074A1 (en) | 2009-12-14 | 2011-06-15 | Robert Steinfeld | Substances and methods for the treatment of lysosmal storage diseases |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5223424A (en) * | 1985-09-06 | 1993-06-29 | Prutech Research And Development | Attenuated herpesviruses and herpesviruses which include foreign DNA encoding an amino acid sequence |
| US5310668A (en) * | 1986-06-20 | 1994-05-10 | Merck & Co., Inc. | Varicella-zoster virus as a live recombinant vaccine |
| US5324664A (en) * | 1988-08-08 | 1994-06-28 | The Upjohn Company | Herpes virus thymidien kinase-encoding DNA |
| FR2659349B1 (fr) * | 1990-03-12 | 1993-12-24 | Rhone Merieux | Virus herpes recombinants notamment pour la realisation de vaccins, leur procede de preparation, les plasmides realises au cours de ce procede et les vaccins obtenus. |
| WO1995026751A1 (en) * | 1994-03-30 | 1995-10-12 | Virogenetics Corporation | NUCLEOTIDE AND AMINO ACID SEQUENCES OF CANINE HERPESVIRUS gB, gC and gD AND USES THEREFOR |
| US5753235A (en) * | 1996-02-15 | 1998-05-19 | Heska Corporation | Recombinant canine herpesviruses |
-
1996
- 1996-02-15 US US08/602,010 patent/US5753235A/en not_active Expired - Lifetime
- 1996-07-12 US US08/680,726 patent/US5804197A/en not_active Expired - Lifetime
-
1997
- 1997-02-14 DE DE69737058T patent/DE69737058T2/de not_active Expired - Lifetime
- 1997-02-14 NZ NZ331079A patent/NZ331079A/en not_active IP Right Cessation
- 1997-02-14 DK DK97915994T patent/DK0910406T3/da active
- 1997-02-14 AT AT97915994T patent/ATE347375T1/de active
- 1997-02-14 JP JP9529621A patent/JP2000505297A/ja active Pending
- 1997-02-14 PT PT97915994T patent/PT910406E/pt unknown
- 1997-02-14 AU AU23278/97A patent/AU728676B2/en not_active Ceased
- 1997-02-14 ES ES97915994T patent/ES2281098T3/es not_active Expired - Lifetime
- 1997-02-14 CA CA002243662A patent/CA2243662A1/en not_active Abandoned
- 1997-02-14 WO PCT/US1997/004115 patent/WO1997029772A1/en not_active Ceased
- 1997-02-14 EP EP97915994A patent/EP0910406B1/en not_active Expired - Lifetime
-
1998
- 1998-01-29 US US09/092,409 patent/US6159478A/en not_active Expired - Lifetime
-
2002
- 2002-05-28 US US10/156,275 patent/US7041813B2/en not_active Expired - Lifetime
-
2006
- 2006-03-13 US US11/374,406 patent/US20060275796A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| US7041813B2 (en) | 2006-05-09 |
| DE69737058T2 (de) | 2007-09-06 |
| WO1997029772A1 (en) | 1997-08-21 |
| PT910406E (pt) | 2007-03-30 |
| DK0910406T3 (da) | 2007-04-10 |
| US6159478A (en) | 2000-12-12 |
| EP0910406A4 (en) | 2000-01-26 |
| US20060275796A1 (en) | 2006-12-07 |
| EP0910406B1 (en) | 2006-12-06 |
| ES2281098T3 (es) | 2007-09-16 |
| US5804197A (en) | 1998-09-08 |
| US5753235A (en) | 1998-05-19 |
| AU2327897A (en) | 1997-09-02 |
| EP0910406A1 (en) | 1999-04-28 |
| NZ331079A (en) | 2000-06-23 |
| CA2243662A1 (en) | 1997-08-21 |
| DE69737058D1 (de) | 2007-01-18 |
| JP2000505297A (ja) | 2000-05-09 |
| US20030049844A1 (en) | 2003-03-13 |
| AU728676B2 (en) | 2001-01-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE347375T1 (de) | Rekombinante hunde-herpesviren | |
| ES2664505T3 (es) | Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas | |
| CY1121353T1 (el) | Anti-tnf αντισωματα, συνθεσεις, μεθοδοi και χρησεις | |
| CY1119650T1 (el) | Anti-il-12 αντισωματα, συνθεσεις, μεθοδοι και χρησεις | |
| CY1114265T1 (el) | Πρωτεϊνη συντηξης αλβουμινης | |
| WO2002097048A3 (en) | ANTI-p40 IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES | |
| DE59410380D1 (de) | Endosomolytisch wirksame partikel | |
| NO20013701D0 (no) | HER-2/neu-fusjonsproteiner | |
| NO20000850D0 (no) | Vaksine | |
| ATE430200T1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
| RU95105518A (ru) | Применение мутантов вируса герпеса, вакцина | |
| WO1991002805A3 (en) | Recombinant retroviruses delivering vector constructs to target cells | |
| CY1107351T1 (el) | Καινοφανης μεταλλαγμενη μορφη απιμινασης αργινινης | |
| ATE420190T1 (de) | Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen | |
| WO2003035847A3 (en) | Il-13 mutein proteins, antibodies, compositions, methods and uses | |
| DE60035337D1 (de) | Humane Peptide/Proteine, die das Töten von Zellen, einschliesslich lymphoide Tumorzellen, herbeiführen oder bewirken | |
| EA200100302A1 (ru) | Способы и композиции для протективной и терапевтической генетической иммунизации | |
| WO2003030821A3 (en) | Albumin fusion proteins | |
| TW200508246A (en) | Anti-dengue virus antibodies, compositions, methods and uses | |
| WO2003038041A3 (en) | Il-4 mutein proteins, antibodies, compositions, methods and uses | |
| WO1999061618A3 (en) | Canine and feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
| WO2001040313A3 (en) | Feline immunoregulatory proteins, nucleic acid molecules, and uses thereof | |
| WO2003057821A3 (en) | Mut-il-18 or mut-il-18r proteins, antibodies, compositions, methods and uses | |
| CY1109023T1 (el) | Gm-αρνητικα μεταλλαγματα ehv | |
| BR9815496A (pt) | Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0910406 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |